Herbalife Limited achieved net sales growth for the first time since early 2024, with Q3 sales reaching $1.3 billion, up 2.7% year-over-year, driven by strong operational execution and growth in North America.
- North America marked its first quarterly sales increase since Q2 2021, reflecting nearly two years of strategic execution.
- Adjusted EBITDA of $163 million surpassed guidance, while total leverage ratio improved to 2.8x, below the 3x commitment.
- The beta launch of Pro2col saw strong engagement from 7,900 distributors, with users logging significant health and wellness activities.
- New distributor growth surged in North America by 17%, highlighting a robust recruitment strategy amidst overall worldwide decline.
Community Discussion